Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Completed 3Not yet recruiting 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 14Gastrointestinal 13Gynecologic 7Thoracic 5Head & Neck 5Dermatologic 5Tumor-Agnostic 3CNS 3Sarcoma 2Genitourinary 2Other solid neoplasm 1

Conditions

Brain Neoplasms 2Suspected Central Nervous System Tumors 1Intracranial Arteriovenous Malformations 1Intracranial Aneurysm 1

Interventions

Temozolomide 299Radiotherapy 219Bevacizumab 139Carboplatin 91Cyclophosphamide 88Etoposide 82Filgrastim 72Vincristine 69Irinotecan 69Magnetic Resonance Spectroscopy 65Cisplatin 59Radiation 58Radiosurgery 52Surgical Procedures, Operative 41Peripheral Blood Stem Cell Transplantation 40Topotecan 39Doxorubicin 39Lomustine 37Carmustine 36sargramostim 35Granulocyte Colony-Stimulating Factor 35Melphalan 34Nivolumab 32Chemotherapy, Adjuvant 32Radiotherapy, Intensity-Modulated 29Isotretinoin 29Everolimus 29Erlotinib Hydrochloride 27Thiotepa 25Vorinostat 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Indocyanine Green × CNS × Clear all
NCT03262636 2026-01-23

TumorGlow(TM)

University of Pennsylvania

Phase 1 Completed
363 enrolled
CNS

Brain Neoplasms

NCT03888014 2023-01-18

Intraoperative Fluorescence With Augmented Reality

Cedars-Sinai Medical Center

Completed
7 enrolled
CNS

Brain Neoplasms, Intracranial Aneurysm, Intracranial Arteriovenous Malformations

NCT02710240 2021-10-27

Indocyanine Green for Central Nervous System Tumors

Abramson Cancer Center at Penn Medicine

Phase 1/2 Completed
336 enrolled 7 charts
CNS

Suspected Central Nervous System Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡